Suchergebnisse - "Marotte, Hubert"

PubPharm (8)

1

Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies

enthalten in: JAMA network open | 2023

von Bitoun, S. | Hässler, S. | Ternant, D. | +40

2

Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease : a prospective study

enthalten in: Inflammatory bowel diseases | 2013

von Paul, S. | Del Tedesco, E. | Marotte, H. | +6

3

Biomarkers for prediction of TNFalpha blockers response in rheumatoid arthritis

enthalten in: Joint bone spine | 2010

von Marotte, H. | Miossec, P.

4

Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis

enthalten in: Muscle & nerve | 2008

von Kerkeni, S. | Marotte, H. | Miossec, P.

5

Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor

enthalten in: Arthritis and rheumatism | 2008

von Marotte, H. | Arnaud, B. | Diasparra, J. | +2

6

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

enthalten in: Arthritis research & therapy | 2007

von Marotte, H. | Pallot-Prades, B. | Grange, L. | +3

CommentIn: Arthritis Res Ther. 2007;9(4):107. - PMID 17850677

7

Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment

enthalten in: Arthritis and rheumatism | 2006

von Toh, M. | Marotte, H. | Blond, J. | +4

8

Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab : link to clinical response

enthalten in: Arthritis research & therapy | 2005

von Marotte, H. | Maslinski, W. | Miossec, P.

1
[1]